Edition:
United Kingdom

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

5.16USD
17 Oct 2018
Change (% chg)

$-0.04 (-0.77%)
Prev Close
$5.20
Open
$5.17
Day's High
$5.20
Day's Low
$4.92
Volume
63,483
Avg. Vol
123,999
52-wk High
$7.94
52-wk Low
$3.23

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.19 December 18 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 8.69 10.00 6.12 --
Quarter Ending Mar-19 1 7.50 7.50 7.50 --
Year Ending Dec-18 5 36.87 38.51 32.59 74.20
Year Ending Dec-19 5 41.14 75.44 24.25 64.10
Earnings (per share)
Quarter Ending Dec-18 5 -0.19 -0.15 -0.23 --
Quarter Ending Mar-19 1 -0.23 -0.23 -0.23 --
Year Ending Dec-18 5 -0.66 -0.56 -0.75 1.33
Year Ending Dec-19 5 -0.20 0.69 -0.82 1.91

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 9.09 8.77 0.32 3.50
Quarter Ending Mar-18 8.88 9.74 0.86 9.70
Quarter Ending Dec-17 9.66 8.80 0.86 8.86
Quarter Ending Sep-17 16.06 9.56 6.50 40.46
Quarter Ending Jun-17 7.75 10.01 2.26 29.16

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 8.69 8.69 9.88 9.88 --
Quarter Ending Mar-19 7.50 7.50 7.50 7.50 --
Year Ending Dec-18 36.87 36.87 38.63 38.63 74.20
Year Ending Dec-19 41.14 41.14 41.18 41.18 64.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 0 1
Earnings